Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - AMERITYRE CORPFinancial_Report.xls
EX-32.2 - EX-32.2 - AMERITYRE CORPex32-2.htm
EX-31.1 - EX-31.1 - AMERITYRE CORPex31-1.htm
EX-32.1 - EX-32.1 - AMERITYRE CORPex32-1.htm
EX-31.2 - EX-31.2 - AMERITYRE CORPex31-2.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 

 
FORM 10-Q
 

 
(Mark One)
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended:   March 31, 2015

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________________ to ____________________.
 
Commission file number: 000-50053
GRAPHIC
AMERITYRE CORPORATION
(Exact name of small business issuer as specified in its charter)

NEVADA
87-0535207
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)

1501 INDUSTRIAL ROAD, BOULDER CITY, NEVADA
89005
(Address of principal executive offices)
(Zip Code)

(702) 293-1930
(Issuer’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x   No o
  
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer  ¨      Accelerated filer  ¨      Non-accelerated filer  ¨      Smaller reporting company x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes  ¨  No  x
 
The number of shares outstanding of Registrant’s Common Stock as of May 11, 2015: 41,570,287
 
 
TABLE OF CONTENTS

 
  
PART I - FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

AMERITYRE CORPORATION
Balance Sheets
 
   
March 31,
2015
   
June 30,
2014
 
   
(Unaudited)
       
ASSETS
           
             
CURRENT ASSETS
           
Cash
 
$
280,828
   
$
728,585
 
Accounts receivable - net
   
524,808
     
384,160
 
Accounts receivable - related party - net
   
6,159
     
17,089
 
Inventory - net
   
614,566
     
770,991
 
Prepaid and other current assets
   
121,537
     
39,631
 
                 
Total Current Assets
   
1,547,898
     
1,940,456
 
                 
PROPERTY AND EQUIPMENT
               
Leasehold improvements
   
162,683
     
162,683
 
Molds and models
   
852,204
     
824,979
 
Equipment
   
2,977,623
     
2,966,649
 
Furniture and fixtures
   
114,184
     
105,622
 
Construction in progress
   
-
     
975
 
Software
   
311,632
     
311,632
 
Less - accumulated depreciation
   
(4,038,433
)
   
(3,915,542
)
                 
Total Property and Equipment
   
379,893
     
456,998
 
                 
OTHER ASSETS
               
Patents and trademarks - net
   
262,908
     
286,947
 
Deposits
   
11,000
     
11,000
 
                 
Total Other Assets
   
273,908
     
297,947
 
                 
TOTAL ASSETS
 
$
2,201,699
   
$
2,695,401
 
 
The accompanying notes are an integral part of these financial statements.

 
AMERITYRE CORPORATION
Balance Sheets (Continued)
 
   
March 31,
2015
   
June 30,
2014
 
   
(Unaudited)
       
LIABILITIES AND STOCKHOLDER'S EQUITY
           
             
CURRENT LIABILITIES
           
Accounts payable and accrued expenses
 
$
482,793
   
$
617,678
 
Current portion of long-term debt
   
13,929
     
16,013
 
                 
Total Current Liabilities
   
496,722
     
633,691
 
                 
Long-term debt
   
53,840
     
53,840
 
                 
TOTAL LIABILITIES
   
550,562
     
687,531
 
                 
STOCKHOLDERS' EQUITY
               
Preferred stock: 5,000,000 shares authorized
of $0.001 par value, 2,000,000 shares issued and
outstanding, respectively
   
2,000
     
2,000
 
Common stock: 75,000,000 shares authorized of
$0.001 par value, 41,570,287 and 41,441,620
shares issued and outstanding, respectively
   
41,570
     
41,441
 
Additional paid-in capital
   
62,510,789
     
62,455,820
 
Retained deficit
   
(60,903,222
)
   
(60,491,391
)
                 
Total Stockholders' Equity
   
1,651,137
     
2,007,870
 
                 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
 
$
2,201,699
   
$
2,695,401
 

The accompanying notes are an integral part of these financial statements.

 
AMERITYRE CORPORATION
Statements of Operations
(Unaudited)
 
   
For the Three Months Ended
March 31,
   
For the Nine Months Ended
March 31,
 
   
2015
   
2014
   
2015
   
2014
 
                         
NET SALES
  $ 1,190,841     $ 1,169,324     $ 3,571,901     $ 3,467,451  
                                 
COST OF GOODS SOLD
    851,688       959,434       2,688,553       2,839,577  
                                 
GROSS PROFIT
    339,153       209,890       883,348       627,874  
                                 
EXPENSES
                               
Research and development
    58,146       49,471       155,636       125,839  
Sales and marketing
    140,573       130,186       426,778       351,841  
General and administrative
    189,936       227,116       638,231       662,200  
                                 
Total Expenses
    388,655       406,773       1,220,645       1,139,880  
                                 
LOSS FROM OPERATIONS
    (49,502 )     (196,883 )     (337,297 )     (512,006 )
                                 
OTHER INCOME/(EXPENSE)
                               
Interest expense
    -       (30,919 )     -       (85,711 )
Interest income
    100       -       466       -  
Write-off of deferred financing costs
    -       (40,000 )     -       (40,000 )
Loss on asset disposal
    -       -       -       (1,585 )
Miscellaneous income/(expense)
    -       (2,500 )     -       1,154  
Total Other Income/(Expense)
    100       (73,419 )     466       (126,142 )
                                 
NET LOSS
    (49,402 )     (270,302 )     (336,831 )     (638,148 )
                                 
Preferred Stock Dividend
    (25,000 )     -       (75,000 )     -  
                                 
NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS
  $ (74,402 )   $ (270,302 )   $ (411,831 )   $ (638,148 )
                                 
BASIC AND DILUTED LOSS PER SHARE
  $ (0.00 )   $ (0.01 )   $ (0.01 )   $ (0.02 )
                                 
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING
    41,524,135       40,241,620       41,469,326       39,925,927  
 
The accompanying notes are an integral part of these financial statements.
 
 
AMERITYRE CORPORATION
Statements of Cash Flows
(Unaudited)
 
   
For the Nine Months Ended
March 31,
 
   
2015
   
2014
 
CASH FLOWS FROM OPERATING ACTIVITIES
           
Net Loss
 
$
(336,831
)
 
$
(638,148
)
Adjustments to reconcile net loss to net cash used by operating activities:
               
Depreciation and amortization expense
   
146,930
     
166,324
 
Amortization of discount on convertible note
   
-
     
40,970
 
Change in allowance for bad debt expense (recovery)
   
(8,066
)
   
16,135
 
Stock paid for services
   
5,147
     
-
 
Stock based compensation related to consultant, employee and director options
   
18,638
     
55,766
 
Write-off of deferred financing costs
   
-
     
40,000
 
Gain/Loss on disposal of assets
   
-
     
1,585
 
Changes in operating assets and liabilities:
               
Accounts receivable
   
(121,652
)
   
(120,255
)
Inventory and inventory reserve
   
156,426
     
45,519
 
Prepaid and other current assets
   
(81,906
)    
23,462
 
Accounts payable and accrued expenses
   
(128,385
)
   
106,383
 
Net Cash Used by Operating Activities
   
(349,699
)
   
(262,259
)
CASH FLOWS FROM INVESTING ACTIVITIES
               
Purchase of property and equipment
   
(45,786
)
   
(28,672
)
Net Cash Used by Investing Activities
   
(45,786
)
   
(28,672
)
CASH FLOWS FROM FINANCING ACTIVITIES
               
Proceeds from the issuance of unsecured notes payable
   
-
     
507,222
 
Redemption and payment of convertible and other notes payable
   
(2,084
)
   
(275,999
)
Preferred stock issuance costs
   
(188
)
   
(900
)
Preferred stock dividends
   
(50,000
)    
-
 
Net Cash (Used) Provided by Financing Activities
   
(52,272
)
   
 230,323
 
NET DECREASE IN CASH
   
(447,757
)
   
(60,608
)
CASH AT BEGINNING OF PERIOD
   
728,585
     
108,747
 
CASH AT END OF PERIOD
 
$
280,828
   
$
48,139
 
 
NON-CASH FINANCING ACTIVITIES
               
                 
Interest paid
 
$
 -
   
$
8,154
 
Income taxes paid
 
$
 -
   
$
 -
 
                 
SUPPLEMENTAL SCHEDULE OF CASH FLOW ACTIVITIES
               
                 
Accrual of preferred share dividends
 
$
25,000
   
$
 -
 
Reversal of deferred financing costs
 
$
31,500
   
$
-
 

The accompanying notes are an integral part of these financial statements.
 
 
AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
March 31, 2015
 
NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION
 
The accompanying unaudited condensed financial statements have been prepared by us pursuant to the rules and regulations of the Securities and Exchange Commission.  Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted in accordance with such rules and regulations.  The information furnished in the interim condensed financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements.  We believe the disclosures and information presented are adequate to make the information not misleading.  These interim condensed financial statements should be read in conjunction with our most recent audited financial statements and notes thereto included in our June 30, 2014 Annual Report on Form 10-K.  Operating results for the nine months ended March 31, 2015 are not necessarily indicative of the results that may be expected for the current fiscal year ending June 30, 2015.
 
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Significant accounting policies disclosed therein have not changed since our audited financial statements and notes thereto included in our June 30, 2014 Annual Report on Form 10-K, except as noted below.
 
Trade Receivables
 
We generally charge-off trade receivables that are more than 120 days outstanding as bad-debt expense, unless management believes the amount to be collectable. The charge-off amounts are included in general and administrative expenses.   As of March 31, 2015 and 2014, the reserve for uncollectible accounts was $7,556 and $24,179, respectively.
 
Stock Based-Compensation Expense
 
We account for stock-based compensation under the provisions of Accounting Standards Codification 718, Compensation – Stock Compensation (ASC 718).  Our financial statements as of and for the quarters ended March 31, 2015 and 2014 reflect the impact of ASC 718.  Stock-based compensation expense related to director, employee or consultant options recognized under ASC 718 for the nine months ended March 31, 2015 and 2014 was $18,638 and $55,766, respectively.
 
ASC 718 requires companies to estimate the fair value of share-based payment awards on the date of grant using an option-pricing model.  The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods in our Statement of Operations.  Stock-based compensation expense recognized in our Statements of Operations for the nine months ended March 31, 2015 and 2014 assumes all awards will vest; therefore no reduction has been made for estimated forfeitures.  We have awarded some options with a performance requirement and no amounts will be recorded until the requirement is met.

In fiscal year 2015 we modified our volatility analysis to represent a 2 year historical trend of our stock.  This modification to our valuation analysis related to options results in an immaterial difference to previous methodology and is employed consistently with all new option grants.
 
Basic and Fully Diluted Net Loss Per Share
 
Basic and Fully Diluted net loss per share is computed using the weighted-average number of common shares outstanding during the period.
 
Our outstanding stock options and warrants and shares issuable upon conversion of outstanding convertible notes have been excluded from the basic and fully diluted net loss per share calculation.  We excluded 2,924,000 and 2,532,572 common stock equivalents for the nine months ended March 31, 2015 and 2014, respectively, because they are anti-dilutive.
 
 
AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
March 31, 2015
 
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, Continued
 
Recent Accounting Pronouncements

Recently Adopted and Recently Issued Accounting Guidance

Adopted

In August 2014, the FASB issued ASU 2014-15 Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. The new standard provides guidance around management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern and to provide related footnote disclosures. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2016. Early adoption is permitted. The Company has elected to early adopt the provisions of ASU 2014-10 for these interim financial statements.

Issued

In January 2015, the FASB issued ASU 2015-01, “Income Statement – Extraordinary and Unusual Items (Subtopic 225-20),” which eliminates the concept of extraordinary items. The new guidance is effective for fiscal years and interim periods within those years beginning after December 15, 2015. The new guidance is to be applied prospectively but may also be applied retrospectively to all prior periods presented in the financial statements. Early adoption is permitted provided that the guidance is applied from the beginning of the fiscal year of adoption. We expect to adopt the provisions of this new guidance on July 1, 2016. We do not expect the adoption of the new provisions to have a material impact on our financial condition or results of operations.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the American Institute of Certified Public Accountants, and the SEC, did not, or are not believed by management to, have a material impact on the Company's present or future financial position, results of operations or cash flows.

Related Party Transactions
 
Amerityre’s Chairman of the Board, Timothy L. Ryan, is also the principal owner of Rhino Rubber LLC, a manufacturing and distribution company for solid industrial tires and wheels.  During the nine months ended March 31, 2015 and 2014, Rhino Rubber LLC purchased a total of $6,928 and $6,192, respectively, in tire products from Amerityre.  As of March 31, 2015 and June 30, 2014, the accounts receivable balances for Rhino Rubber LLC were $6,159 and $20,143, respectively.
 
We currently distribute directly from our manufacturing facility in Boulder City, Nevada and in the past from an independent, contracted warehouse in Ravenna, Ohio.  This contract distribution point was unable to support customer requirements, became ineffective and stopped operations in the second quarter of 2014.  In order to keep commitments to customers and keep revenue growth positive, distribution and other related services were transferred to Rhino Rubber in Akron, Ohio.  Costs for these services were limited to freight, shipping and labor for mounting services.  Storage and other fees of $7,722 for the nine months ended March 31, 2015 were charged to the Company by Rhino Rubber and used to offset the above accounts receivable balance.
 
NOTE 3 - INVENTORY

Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or market.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.
 
   
March 31, 2015
   
June 30, 2014
 
   
(Unaudited)
       
Raw Materials
 
$
230,870
   
$
358,725
 
Finished Goods
   
649,936
     
525,722
 
Inventory reserve
   
(266,240
)    
(113,456
)
Inventory - net
 
$
614,566
     
770,991
 
 
Our inventory reserve reflects items that were deemed to be slow moving, defective or obsolete based on an analysis of all inventories on hand.  The Company is actively working with all suppliers who provide out-of-specification inventory on solutions to fix the supplier manufacturing process and reimburse the Company for time and material used in reworking said inventory.

 
AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
March 31, 2015
 
NOTE 4 - STOCK TRANSACTIONS
 
During the second quarter, we granted a consultant 128,667 common shares valued at $0.04 per share ($5,147) for work performed related to sales of our products in the three month period ending December 31, 2014.  These shares were issued in January 2015.

Additionally, in a prior period we had accrued deferred financing costs related to a private placement stock campaign.  Upon further investigation the accrual was in error and reversed in the second quarter of fiscal 2015, resulting in an increase to additional paid in capital.

NOTE 5 - STOCK OPTIONS AND WARRANTS

General Option Information

On July 6, 2011, the Board of Directors cancelled the “2004 Non-Employee Directors’ Stock Incentive Plan” and approved the “Directors’ 2011 Stock Option and Award Plan”.  The Company also maintains the 2005 Stock Option and Award Plan, which was previously approved by stockholders, for the purpose of granting option awards to its employees and consultants.   Under the 2005 Plan, a total of 3,000,000 shares are authorized for issuance, and under the 2011 Plan, a total of 3,300,000 shares are authorized for issuance.

During the nine months ended March 31, 2015, 100,000 options were granted.  Additionally 140,000 options related to this transaction vested (20,000 options monthly May – November 2014 at $0.10); these options were granted to a consultant pursuant to a consulting agreement.  Year to date expense related to these options is $12,022 as of March 31, 2015.

On December 1, 2014, 480,000 options were granted to the Company’s Chief Executive Officer (then our Chief Operating Officer) as part of his employment offer.  The options have a strike price of $0.10, vest December 1, 2015 and expire December 1, 2020.  Year to date expense related to these options is $6,196 as of March 31, 2015.

On January 21, 2015, 50,000 options were granted to the Company’s Chief Financial Officer as part of her employment offer.  The options have a strike price of $0.10, vest ratably January 21, 2015 to December 1, 2015 and expire December 1, 2020.  Year to date expense related to these options is $420 as of March 31, 2015.
 
We estimated the fair value of the stock options at the grant date based on the following weighted average assumptions:
 
Risk-free interest rate
    1.190   1.345
%
Expected life
    3.8   4.5
 years
Expected volatility
    147.43   152.40
%
Dividend yield
        0.00
%
 
A summary of the status of our outstanding stock options as of March 31, 2015 and June 30, 2014 and changes during the periods then ended is presented below:
 
   
March 31, 2015
   
June 30, 2014
 
   
Shares
   
Weighted
Average
Exercise Price
   
Shares
   
Weighted
Average
Exercise Price
 
Outstanding beginning of period
   
1,754,000
   
$
0.17
     
1,904,000
   
$
0.23
 
Granted
   
670,000
   
$
0.10
     
150,000
   
$
0.08
 
Expired/Cancelled
   
-
   
$
-
     
(300,000
)
 
$
0.50
 
Exercised
   
-
   
$
-
     
-
   
$
-
 
Outstanding end of period
   
2,424,000
   
$
0.15
     
1,754,000
   
$
0.17
 
                                 
Exercisable
   
1,906,500
   
$
0.17
     
1,604,000
   
$
0.18
 
 
 
AMERITYRE CORPORATION
Notes to the Unaudited Financial Statements
March 31, 2015
 
NOTE 5 - STOCK OPTIONS AND WARRANTS, Continued
 
The following table summarizes the range of outstanding and exercisable options as of March 31, 2015:

     
Outstanding
   
Exercisable
 
 
Range of
Exercise Prices
   
 
Number Outstanding at
March 31, 2015
   
Weighted
Average
Remaining
Contractual Life
   
 
Weighted
Average
Exercise Price
   
 
Number
Exercisable at
March 31, 2015
   
Weighted
Average Remaining
Contractual Life
 
$
0.08
     
150,000
     
6.67
   
$
0.08
     
150,000
     
6.67
 
$
0.10
     
670,000
     
4.72
   
$
0.10
     
152,500
     
4.72
 
$
0.17
     
650,000
     
4.67
   
$
0.17
     
650,000
     
4.67
 
$
0.17
     
400,000
     
5.67
   
$
0.17
     
400,000
     
5.67
 
$
0.17
     
400,000
     
6.67
   
$
0.17
     
400,000
     
6.67
 
$
0.29
     
154,000
     
0.25
   
$
0.29
     
154,000
     
0.25
 
         
2,424,000
                     
1,906,500
         

General Warrant Information

In September 2013, the Company obtained an extension on the remaining $100,000 secured convertible promissory note that was issued in the private placement that closed in September 2010.  This note was paid off as of June 30, 2014.   In exchange for the extension, the note holder received 500,000 common stock warrants and $6,500 in accrued interest and fees.  The common stock warrants expire three years from the date of issuance, are exercisable at $0.13 per share, and vest on the next date the value of Amerityre common stock reaches $0.25 per share.  As of March 31, 2015 the warrants have not vested.
 
NOTE 6 - LIQUIDITY

At March 31, 2015, our total cash was $280,828, none of which was restricted and our total indebtedness was $550,562, compared to total cash of $48,139 and total indebtedness of $1,618,305 at March 31, 2014.  Our total indebtedness at March 31, 2015 includes $482,793 of accounts payable and accrued expenses and $67,769 of long-term debt (of which $13,929 is current).  As a result, operations for the nine months ended March 31, 2015 consumed $447,757 of the Company’s limited cash resources.

In the third quarter fiscal 2015, our revenue fell short of expectations primarily due to a significant, long term customer not placing its customary order in the second and third quarters.  The lack of this customary order was a significant factor in the Company not achieving the expected milestone of positive cash flows from operations.  This revenue shortfall was partly offset by significant increases in sales of our agricultural pivot tires.

To help address our limited cash resources, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows without diluting our common stock or requiring the addition of debt. We are in discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit.  Lastly, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.

At the Annual Stockholder’s Meeting held on December 4, 2014, management presented a plan focusing on “Profitability as a Mindset”.  To that end, management continues to sharpen our sales model to add sales resources. We have purchased a customer list and placed advertisements in trade magazines to introduce our agriculture products to our targeted customer base. We will continue to implement marketing efforts to develop these potential customers throughout the remainder of fiscal year 2015.

In connection with the preparation of our financial statements for the three and nine months ended March 31, 2015, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.

 
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
This discussion and analysis contains statements of a forward-looking nature relating to future events or our future financial performance or financial condition.  Such statements are only predictions and the actual events or results may differ materially from the results discussed in or implied by the forward-looking statements. The historical results set forth in this discussion and analysis are not necessarily indicative of trends with respect to any actual or projected future financial performance.  This discussion and analysis should be read in conjunction with the financial statements and the related notes thereto included elsewhere in this report.
 
Overview
 
Amerityre incorporated as a Nevada corporation on January 30, 1995 under the name American Tire Corporation and changed its name to Amerityre Corporation in December 1999.
 
Amerityre engages in the research and development, manufacturing and sale of polyurethane tires.  We believe that we have developed unique polyurethane formulations that allow us to make products with superior performance characteristics, including abrasion resistance, energy efficiency and load-bearing capabilities, in comparison to conventional rubber tires.  We also believe that our manufacturing processes are more energy efficient than the traditional rubber tires manufacturing processes, in part because our polyurethane compounds do not require the multiple processing steps, extreme heat, and high pressure that are necessary to cure rubber. Using our polyurethane technologies, we believe tires can be produced which last longer, are less susceptible to failure, are friendly to the environment and offer improved fuel economy.  

In an effort by our government to continually improve the quality of air, land and water it is important to note that select chemicals used in our formulations in the past are becoming difficult to source .With this in mind Amerityre has embarked on a project to find suitable replacements for these products through intensive R&D in a combined effort with our supplier base. As always Amerityre is committed to be compliant with all government regulations while insuring the quality of our products.
  
We are concentrating on three segments of the tire market: closed-cell polyurethane foam tires, polyurethane elastomer forklift tires and agricultural tires. Our most recent activities in these areas are set forth below:
 
Closed-Cell Polyurethane Tires – The sale of polyurethane foam tires to original equipment manufacturers, distributors and dealers accounts for most of our revenue at this time. We have the ability to produce a broad range of products for the low duty cycle tire market. During 2014, we introduced a new low cost formulation positioned to compete within the commodity segment of this market.   Marketing efforts continue to build customer relationships with original equipment manufacturers and further develop distribution networks to expand business and product sales.
 
Polyurethane Elastomer Forklift Tires – Manufacturing was suspended in the second quarter of 2013 due to quality and process issues.  We engaged a polyurethane specialist to lead the corrective action efforts and complete the development of a marketable forklift tire.  During 2014, the forklift product line was reintroduced into the marketplace. This process has been slow given the poor product performance experienced in 2012 and 2013.  Results continue to be below expectations, and we are currently undertaking a project to source suitable formulation components to replace those difficult to source, as mentioned above.  We expect results to continue to lag expectations until the modified formulation is completed and a new marketing campaign for this product launched.
 
Agricultural Tires – This product continues to demonstrate revenue growth during the period. With market acceptance and growing revenues for this new product line, we have placed additional resources to ensure product improvements and developments continue to expand at high levels.  We continue to work to establish distribution relationships to increase our market penetration in this segment.  Our market knowledge continues to grow as evidenced by several new product designs we have implemented during the period and a new design patent we hold.  This patent will protect the Company’s interest going forward and we anticipate we can bolster future revenues by providing application-specific solutions for customers.

Due to the Company’s limited resources, tire projects which are contingent on additional development, such as composite and automotive tires, have been put on hold and will be revisited at a later date.
 
 
As described above, the market segments we are focused on are diverse markets which are unrelated in terms of customer base, product, distribution, market demands and competition. After completing a review of our cost structure, product pricing and marketing approaches, the new management team concluded that the sales organization of the Company should be organized according to a territory sales management approach rather than a product management approach. As a result, the sales team is comprised of three manufacturer representatives whose experience is complementary to our product portfolio plus our in-house sales department.  The result of the Company’s emphasis on proper product pricing and new marketing campaigns has driven more profitable sales for Amerityre, which has become evident in our third quarter 2015 results.  Our net loss decreased and our EBITDA (earnings before income taxes depreciation and amortization, a normalizing/non-GAAP metric) is positive for the quarter.  Overall these changes are supporting our goal in establishing “Profitability as a Mindset”.  
 
Factors Affecting Results of Operations
 
Our operating expenses consisted primarily of the following:
 
 
·  
Cost of sales, which consists primarily of raw materials, components and production of our products, including applied labor costs and benefits expenses, maintenance, facilities and other operating costs associated with the production of our products;

 
·  
Selling, general and administrative expenses, which consist primarily of salaries, commissions and related benefits paid to our employees and related selling and administrative costs including professional fees;

 
·  
Research and development expenses, which consist primarily of direct labor conducting research and development, equipment and materials used in new product development and product improvement using our technologies;

 
·  
Consulting expenses, which consist primarily of amounts paid to third-parties for outside services;

 
·  
Depreciation and amortization expenses which result from the depreciation of our property and equipment, including amortization of our intangible assets; and

 
·  
Stock based compensation expense related to stock and stock option awards issued to employees and consultants for services performed for the Company.
 
Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with United States generally accepted accounting principles.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, sales and expenses.  On an ongoing basis, we evaluate our estimates, including those related to uncollectible receivables, inventory valuation, deferred compensation and contingencies.  We base our estimates on historical performance and on various other assumptions that we believe to be reasonable under the circumstances.  These estimates allow us to make judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.

We believe the following accounting policies are our critical accounting policies because they are important to the portrayal of our financial condition and results of operations and they require critical management judgments and estimates about matters that may be uncertain.  If actual results or events differ materially from those contemplated by us in making these estimates, our reported financial condition and results of operations for future periods could be materially affected.

Revenue Recognition

Revenue for products is recognized when the sales amount is determined, shipment of goods to the customer has occurred and collection is reasonably assured. Generally, we ship all of our products FOB origination.

Valuation of Intangible Assets and Goodwill

Patent and trademark costs have been capitalized at March 31, 2015, totaling $590,192 with accumulated amortization of $327,284 for a net book value of $262,908. Patent and trademark costs, net of accumulated amortization at March 31, 2014 totaled $286,947.

The patents which have been granted are being amortized over a period of 20 years. Patents which are pending or are being developed are not amortized. Amortization begins once the patents have been issued. Included in the total patent and trademark costs are $-0- and $6,207 of patent and trademark costs pending at March 31, 2015 and 2014, respectively, that were not being amortized.  

 
The Company evaluates the recoverability of intangibles and reviews the amortization period on a continual basis utilizing the guidance of Accounting Standards Codification (“ASC”) 350, Intangibles – Goodwill and Other.  We consider the following indicators, among others, when determining whether or not our patents are impaired:

 
·  
any changes in the market relating to the patents that would decrease the life of the asset;

 
·  
any adverse change in the extent or manner in which the patents are being used;

 
·  
any significant adverse change in legal factors relating to the use of the patents;

 
·  
current period operating or cash flow loss combined with our history of operating or cash flow losses;

 
·  
future cash flow values based on the expectation of commercialization through licensing; and
 
 
·  
current expectations that, more likely than not, the patents will be sold or otherwise disposed of significantly before the end of its previously estimated useful life.
          
Inventory
 
Inventory is stated at the lower of cost (computed on a first-in, first-out basis) or market.  The inventory consists primarily of chemicals, finished goods produced in our plant and products purchased for resale.
 
Stock-Based Compensation
 
Equity securities issued for services rendered have been accounted for at the fair market value of the securities on the date of authorization.  The stock-based compensation expense recognized under ASC 718 for the nine months ended March 31, 2015 and 2014 was $18,638 and $55,766, respectively. The stock-based compensation expense recognized under ASC 718 for the three months ended March 31, 2015 and 2014 was $5,067 and $19,976, respectively.
 
Results of Operations
 
Our management reviews and analyzes several key performance indicators in order to manage our business and assess the quality and potential variability of our sales and cash flows.  These key performance indicators include:
 
 
·  
Net sales, which consist of product sales;
 
 
·  
Sales, net of returns and trade discounts, which is an indicator of our overall business growth and the success of our sales and marketing efforts;
 
 
·  
Gross profit, which is an indicator of both competitive pricing pressures and the cost of goods sold of our products and the mix of product and license fees, if any;
 
 
·  
Growth in our customer base, which is an indicator of the success of our sales efforts; and
 
 
·  
Distribution of sales across our products offered.
 
 
The following summary table presents a comparison of our results of operations for the three and nine months ended March 31, 2015 and 2014 with respect to certain key financial measures.  The comparisons illustrated in the table are discussed in greater detail below. 
 
   
For the Three Months Ended
March 31,
       
For the Nine Months Ended
March 31,
       
   
(in 000’s)
   
Change
 
(in 000’s)
   
Change
 
   
2015
   
2014
   
2015 vs. 2014
 
2015
   
2014
   
2015 vs. 2014
 
Net revenues
 
$
1,191
   
$
1,169
     
1.9
%
 
$
3,572
   
$
3,467
     
3.0
%
Cost of revenues
   
(852
   
(959
   
(11.2
%)
   
(2,689
)    
(2,840
)    
(5.3
%)
Gross profit
   
339
     
210
     
61.4
%
   
883
     
628
     
40.6
%
Research  and development expenses
   
(58
)    
(49
)
   
18.4
%
   
(156
)    
(126
)    
23.8
%
Sales and marketing expense
   
(141
   
(130
)
   
8.5
%
   
(427
)    
(352
)    
21.3
%
General and administrative expense
   
(190
   
(228
)
   
(16.7
%)
   
(638
   
(662
)    
(3.8
%)
Other income (expense)
   
-
     
(73
)
   
(100.0
%)
   
-
     
(126
)
   
(100.0
%)
Net loss
   
(50
)
   
(270
)
   
(81.5
%)
   
(337
)
   
(638
)
   
(47.2
%)
Preferred stock dividend
   
(25
)
   
-
     
100.0
%
   
(75
)
   
-
     
100.0
%
Net loss attributable to common shareholders
 
$
(75
)
 
$
(270
)
   
(72.2
%)
 
$
(412
)
 
$
(638
)
   
(35.4
%)
 
Three Months Ended March 31, 2015 Compared to March 31, 2014
 
Net Sales.  Net sales of $1,190,841 for the three months ended March 31, 2015, reflects a 1.9% increase over net sales of $1,169,324 for the three months ended March 31, 2014. Sales between periods increased largely due to increases in the agricultural product line.

Cost of Revenues.  Cost of revenues for the three months ended March 31, 2015 was $851,688 or 71.5% of sales compared to $959,434 or 82.1% of sales for the same period in 2014, representing a savings of 11.2% year over year. Cost of revenues decreased for the three months ended due to decreases in raw materials offset by higher direct labor and overhead when compared to prior year.  Although direct labor is higher in the current year then the prior year, we believe that we have the correct mix of personnel and higher skill sets on the production floor that will support other growth initiatives in the Company.
 
Gross Profit.  Gross profit for three months ended March 31, 2015 was $339,153 compared to $209,890 for the same period in 2014. Gross profit increased by $129,263 or 61.4% between periods directly as a result of increases in net sales and decreases in cost of revenues.
 
Research & Development Expenses.  Research and development expenses for the three months ended March 31, 2015 were $58,146 compared to $49,471 for the same period in 2014. Research and development expenses between periods increased by $8,675 or 18.4% primarily due to increased testing and research expense, and associated labor, incurred in the quarter.  All other expenses were generally consistent.

Sales & Marketing Expenses. Sales and marketing expenses for the three months ended March 31, 2015 were $140,573 compared to $130,186 for the same period in 2014. Sales and marketing expenses increased $10,387 between periods primarily due to higher commissions to outside sales representatives, higher travel expense to trade shows and higher advertising through trade magazines for our products.  All other expenses were generally consistent.

General & Administrative Expenses.  General and administrative expenses for the three months ended March 31, 2015 were $189,936 compared to $227,116 for the same period in 2014. General and administrative expenses decreased $37,180 or 16.3% between periods primarily due to savings in salaries and wages, lower stock based compensation, lower depreciation and lower bad debt expense offset by increases in consulting and accounting expenses.  All other expenses were generally consistent.
 
Other Income/(Expense).  Other income for the three months ended March 31, 2015 was $100 compared to ($73,419) for the same period in 2014. Other income/(expense) increased $73,519 between periods due to our ability to pay off all unsecured notes and short-term borrowings in 2014 resulting in no cost of debt in the current period.
 
Net Loss.  Net loss for the three months ended March 31, 2015 was $49,402 compared to a net loss of $270,302 for the same period in 2014, a decrease of $220,900.  However, net loss to common shareholders only decreased by $195,900 or 72.6% due to the preferred share dividend.
 

Nine Months Ended March 31, 2015 Compared to March 31, 2014
 
Net Sales.  Net sales of $3,571,901 for the nine months ended March 31, 2015, reflects a 3.0% increase over net sales of $3,467,451 for the nine months ended March 31, 2014. Sales between periods increased largely due to increases in the agricultural product line offset by a large long term customer not placing its customary order in the third quarter.  This client is restructuring its product line and we anticipate future sales to the client in our next fiscal year.

Cost of Revenues.  Cost of revenues for the nine months ended March 31, 2015 was $2,688,553 or 75.3% of sales compared to $2,839,577 or 81.9% of sales for the same period in 2014. Cost of revenues decreased for the nine months ended due to decreases in raw materials and overhead offset by higher direct labor when compared to the prior year.
 
Gross Profit.  Gross profit for nine months ended March 31, 2015 was $883,348 compared to $627,874 for the same period in 2014. Gross profit increased by $255,474 or 40.6% between periods directly as a result of increases in net sales and decreases in cost of revenues.
 
Research & Development Expenses.  Research and development expenses for the nine months ended March 31, 2015 were $155,636 compared to $125,839 for the same period in 2014. The $29,797 increase between periods is primarily due to increased testing and research expense, and associated labor, and testing expense, primarily related to finding a replacement catalyst in our manufacturing process, incurred year to date.  All other expenses were generally consistent.

Sales & Marketing Expenses. Sales and marketing expenses for the nine months ended March 31, 2015 were $426,778 as compared to $351,841 for the same period in 2014. Sales and marketing expenses increased $74,937 between periods primarily due higher commissions to outside sales representatives, higher travel expense to trade shows and higher advertising through trade magazines for our products. All other expenses were generally consistent.

General & Administrative Expenses.  General and administrative expenses for the nine months ended March 31, 2015 were $638,231 compared to $662,200 for the same period in 2014. General and administrative expenses decreased $23,969 or 3.6% between periods primarily due to savings in salaries and wages, lower stock based compensation, lower depreciation and lower bad debt expense offset by increases in consulting and accounting expenses.  All other expenses were generally consistent.
 
Other Income/(Expense).  Other income for the nine months ended March 31, 2015 was $466 compared to ($126,142) for the same period in 2014. Other income/(expense) increased $126,608 between periods due to our ability to pay off all unsecured notes and short-term borrowings in 2014 resulting in no cost of debt in the current period.

Net Loss.  Net loss for the nine months ended March 31, 2015 was $336,831 compared to a net loss of $638,148 for the same period in 2014, a decrease of $301,317.  However, net loss to common shareholders decreased by $226,317 or 35.4% due to the preferred share dividend.

Liquidity and Capital Resources

Our principal sources of liquidity consist of cash and payments received from our customers.  We do not have any significant credit arrangements.  Historically, our expenses have exceeded our sales, resulting in operating losses.  From time to time, we have obtained additional liquidity to fund our operations through the sale of shares of our common stock and the placement of short-term debt instruments.   Management continues to evaluate financing options but we are choosing to delay financing at terms that will subject the Company to high costs of debt and are reluctant to raise money through stock sales at what we believe are highly dilutive share prices.

As we have historically not succeeded in establishing favorable short term financing, in the quarter ending March 31, 2015, we have entered into a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.

 
Cash Flows
 
The following table sets forth our cash flows for the nine months ended March 31, 2015 and 2014.
 
   
For the Nine Months Ended
March 31,
 
   
(in 000’s)
 
   
2015
   
2014
 
Net Cash Used by Operating Activities
 
$
(350
)  
$
(262
Net Cash Used by Investing Activities
   
(46
)    
(29
)
Net Cash (Used) Provided by Financing Activities
   
(52
)    
230
 
Net Decrease in Cash During Period
 
$
(448
)  
$
(61

Net Cash Used by Operating Activities. Our primary sources of operating cash during the period ended March 31, 2015 came from collections from customers, however due to higher quarter end customer purchases our accounts receivable was also higher at period end. Our primary use of operating cash was an increase in inventory on hand at period end.  Net cash used by operating activities was $349,699 for the period ended March 31, 2015 compared to net cash used by operating activities of $262,259 for the same period in 2014. 
  
Net Cash Used by Investing Activities.  Net cash used by investing activities was $45,786 for the period ended March 31, 2015 and $28,672 for the same period in 2014.  Our use of cash for the period ended March 31, 2015 was for the purchase of models, equipment and software, all used in the manufacturing process.  

Net Cash (Used) Provided by Financing Activities.  Net cash used by financing activities was $52,271 for the period ended March 31, 2015 compared to net cash provided by financing activities of $230,323 for the same period last year. The primary use of cash for the period ended March 31, 2015 was the payment of $50,000 for the preferred stock dividend.
 
Contractual Obligations and Commitments
 
The following table summarizes our contractual cash obligations and other commercial commitments at March 31, 2015.
 
   
Payments due by period
 
   
Total
   
Less than 1 year
   
1 to 3 years
   
3 to 5 years
   
After 5 years
 
Facility lease (1)
 
$
33,000
   
$
33,000
   
$
-
   
$
-
   
$
-
 
Total contractual cash obligations
 
$
33,000
   
$
33,000
   
$
-
   
$
-
   
$
-
 
                                           

(1)  In May 2014, we negotiated a one year extension of the lease on our executive office and manufacturing facility located at 1501 Industrial Road, Boulder City, Nevada.  The property consists of a 49,200 square foot building of which the landlord has negotiated to possibly occupy 7,000 square feet.  This space is not critical to our manufacturing processes and will not interrupt current business operations.  We currently occupy all 49,200, inclusive of approximately 5,500 square feet of office space, situated on approximately 4.15 acres.   The extended lease commenced on July 1, 2014 for the base rent of $11,000 per month.  All other terms and conditions of the building lease remain in effect. The facility lease is in negotiations for extension with generally the same terms for an additional 5 years.
 
Cash Position, Outstanding Indebtedness and Future Capital Requirements
 
At May 4, 2015, our total cash balance was $377,861 none of which is restricted; accounts receivables, net of reserves for bad debt, was $301,269; and inventory, net of reserves for slow moving or obsolete inventory, and other current assets was $1,030,572. Our total indebtedness was $629,423.  Our total indebtedness at May 4, 2015 includes $479,773 in accounts payable, $4,363 in interest for notes and short-term borrowings, $77,518 in accrued expenses, $13,929 in current portion of long-term debt and $53,840 in long-term debt.

Over the past year, we have been working on various proposals to secure short-term loans as well as long-term bank financing and equity based investments. This work resulted in $507,222 in proceeds from unsecured notes payable and our ability to place Preferred Shares resulting in proceeds of $1,980,478, net of offering costs.  These funds enabled us to pay off $867,257 in debt from 2014 and 2013, fund operations, plus keep operating cash available to fund fiscal year 2015 initiatives as we grow our revenue while maintaining a stable cost basis.
 
 
The Company currently does not have an existing credit facility. Over the past year, we have worked with our vendors to obtain extended credit terms and increase credit lines. We also continue to maintain strong customer credit policies and procedures and aggressively pursue receivable collections. 

We are intent, in spite of losing a significant number of sales growth opportunities due to cash flow constraints, on focusing on the sale and distribution of profitable product lines. Management continues to look for a facility at affordable terms that will allow the Company to maintain sufficient raw material and finished goods inventory to capitalize on sales growth opportunities. No additional capital expenditures are anticipated over the next twelve months unless they support sales development and product improvement.  We continue to work to reduce our overall costs wherever possible.

In the third quarter fiscal 2015, our revenue fell short of expectations primarily due to a large long term customer not placing its customary order in the second and third quarter.  The lack of this customary order was a significant factor in the Company not achieving the expected milestone of achieving positive cash flows from operations. This revenue shortfall was partly offset by significant increases in sales of our agricultural pivot tires.

To help address our limited cash resources, we are in discussions with various third parties about potential opportunities to license our technology which we believe will bring in additional cash flows without diluting our common stock or requiring the addition of debt. We are in discussions with banks and other lenders regarding establishing a line of credit for short term cash needs, however at this time we have not succeeded in establishing such a line of credit.  Lastly, we have entered in a short term receivable factoring agreement with a third party to sell our receivable invoices.  This agreement enables us to sell individual customer invoices for faster cash flow to the Company as we deem needed.

At the Annual Stockholder’s Meeting held on December 4, 2014, management presented a plan focusing on “Profitability as a Mindset”.  To that end, management continues to sharpen our sales model continue to add sales resources. The result of this this new emphasis on proper product pricing and new marketing campaigns has driven more profitable sales for Amerityre, which has started to demonstrate traction as evidenced in our third quarter 2015 results. Our net loss decreased and our EBITDA (earnings before income taxes depreciation and amortization, a normalizing/non-GAAP metric) is positive for the quarter.  Overall these changes are supporting our goal in establishing “Profitability as a Mindset” and management and the Company’s Board of Directors are committed to this trend. 

As of March 31, 2015 the Company has approximately 10,437,000 shares authorized and available for issuance. Although we are reluctant to raise money through stock sales at what we believe are dilutive share prices, these authorized but unissued and unreserved shares of our common stock can be utilized if necessary to fund the expansion of our manufacturing operations or to obtain additional working capital.
 
In assessing our liquidity, management reviews and analyzes our current cash, accounts receivable, accounts payable, capital expenditure commitments and other obligations.  In connection with the preparation of our financial statements for the three and nine months ended March 31, 2015, we have analyzed our cash needs for the next twelve months. We have concluded that our available cash and accounts receivables are sufficient to meet our current minimum working capital, capital expenditure and other cash requirements for this period.
 
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to changes in prevailing market interest rates affecting the return on our investments but do not consider this interest rate market risk exposure to be material to our financial condition or results of operations.  We invest primarily in United States Treasury instruments with short-term (less than one year) maturities.  The carrying amount of these investments approximates fair value due to the short-term maturities.  Under our current policies, we do not use derivative financial instruments, derivative commodity instruments or other financial instruments to manage our exposure to changes in interest rates or commodity prices.
 
ITEM 4. CONTROLS AND PROCEDURES

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives.

As required by SEC Rule 13a-15(b), an evaluation was performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934) as of the end of the period covered by this report. Based upon that evaluation,  our Chief Executive Officer and our Chief Financial Officer, concluded that the design and operation of these disclosure controls and procedures were effective at the reasonable assurance level. There has been no change in our internal controls over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.
 
 
 PART II - OTHER INFORMATION
 
ITEM 1.  LEGAL PROCEEDINGS

None.
 
ITEM 1A. RISK FACTORS

For information regarding risk factors, see “Part I. Item 1A. Risk Factors,” in our Annual Report on Form 10-K for the year ended June 30, 2014.

We believe the additional risk factors outlined in our Quarterly Report on Form 10-Q for the period ended December 31, 2014 are no longer significant business risks because we have found a suitable chemical catalyst replacement for our product formulations, and the west coast ports have resolved the labor disputes affecting international shipments.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.
 
ITEM 3.  DEFAULTS UPON SENIOR SECURITIES

None.
 
ITEM 4.  MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5.  OTHER INFORMATION

None.
 
ITEM 6.  EXHIBITS
 
31.1
   
31.2
   
32.1
   
32.2
   
101 INS
XBRL Instance Document
   
101 SCH
XBRL Taxonomy Extension Schema Document
   
101 CAL
XBRL Taxonomy Extension Calculation Linkbase Document
   
101 DEF
XBRL Taxonomy Extension Definition Linkbase Document
   
101 LAB
XBRL Taxonomy Extension Label Linkbase Document
   
101 PRE
XBRL Taxonomy Extension Presentation Linkbase Document
 
 
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated:  May 11, 2015
 
AMERITYRE CORPORATION
     
By:
     
/s/ Michael F. Sullivan
 
/s/ Lynda R. Keeton-Cardno
 
Michael F. Sullivan
Chief Executive Officer
(Principal Executive Officer)
 
Lynda R. Keeton-Cardno
Chief Financial Officer
(Principal Financial and Accounting Officer)
 
 
 
 
19